Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial - Sharma, Padmanee; Jäger, Dirk (The lancet. Oncology, 2016)
Gesehen am 25.10.2017